ESCMID Online Lecture Library. by author

Similar documents
THERAPY OF ANAEROBIC INFECTIONS LUNG ABSCESS BRAIN ABSCESS

Secondary peritonitis

Intra-Abdominal Infections. Jessica Thompson, PharmD, BCPS (AQ-ID) Infectious Diseases Pharmacy Clinical Specialist Renown Health April 19, 2018

National Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults

Necrotizing Soft Tissue Infections: Emerging Bacterial Resistance

Case 2 Synergy satellite event: Good morning pharmacists! Case studies on antimicrobial resistance

Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing

Felipe N. Gutierrez MD, MPH Chief, Infectious Diseases Phoenix VA Healthcare

Diabetic Foot Infection. Dr David Orr Consultant Microbiologist Lancashire Teaching Hospitals

Approach to pediatric Antibiotics

Antimicrobial Update. Alison MacDonald Area Antimicrobial Pharmacist NHS Highland April 2018

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting

ESCMID Online Lecture Library. by author

Antibiotic Updates: Part II

General Approach to Infectious Diseases

PIPERACILLIN- TAZOBACTAM INJECTION - SUPPLY PROBLEMS

The β- Lactam Antibiotics. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018

PRACTIC GUIDELINES for APPROPRIATE ANTIBIOTICS USE

Should we test Clostridium difficile for antimicrobial resistance? by author

GASTRO-INTESTINAL TRACT INFECTIONS - ANTIMICROBIAL MANAGEMENT

Interactive session: adapting to antibiogram. Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe

Einheit für pädiatrische Infektiologie Antibiotics - what, why, when and how?

Scottish Medicines Consortium

Safe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times

Medicinal Chemistry 561P. 2 st hour Examination. May 6, 2013 NAME: KEY. Good Luck!

Treatment of septic peritonitis

Antibiotic Abyss. Discussion Points. MRSA Treatment Guidelines

مادة االدوية المرحلة الثالثة م. غدير حاتم محمد

Chapter Anaerobic infections (individual fields): prevention and treatment of postoperative infections

2015 Antibiogram. Red Deer Regional Hospital. Central Zone. Alberta Health Services

Symptoms of cellulitis (n=396) %

Antibacterial therapy 1. د. حامد الزعبي Dr Hamed Al-Zoubi

Copyright 2012 Diabetes In Control, Inc. For permission to reprint, please contact Heather Moran, Production Editor, at

Childrens Hospital Antibiogram for 2012 (Based on data from 2011)

Antimicrobial Susceptibility Testing: Advanced Course

2015 Antibiotic Susceptibility Report

Infection Comments First Line Agents Penicillin Allergy History of multiresistant. line treatment: persist for >7 days they may be

Cellulitis. Assoc Prof Mark Thomas. Conference for General Practice Auckland Saturday 28 July 2018

Treatment of Surgical Site Infection Meeting Quality Statement 6. Prof Peter Wilson University College London Hospitals

Appropriate Management of Common Pediatric Infections. Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases

Basic principles of antibiotic use

Super Bugs and Wonder Drugs: Protecting the One While Respecting the Many

Aberdeen Hospital. Antibiotic Susceptibility Patterns For Commonly Isolated Organisms For 2015

General Surgery Small Group Activity (Facilitator Notes) Curriculum for Antimicrobial Stewardship

2016 Antibiotic Susceptibility Report

Antimicrobials. Antimicrobials

2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

Pharmacology Week 6 ANTIMICROBIAL AGENTS

Perichondritis: Source: UpToDate Ciprofloxacin 10 mg/kg/dose PO (max 500 mg/dose) BID Inpatient: Ceftazidime 50 mg/kg/dose q8 hours IV

B. PACKAGE LEAFLET 1

Other Beta - lactam Antibiotics

SESSION XVI NEW ANTIBIOTICS

VCH PHC SURGICAL PROPHYLAXIS RECOMMENDATIONS

Intro Who should read this document 2 Key practice points 2 Background 2

Routine internal quality control as recommended by EUCAST Version 3.1, valid from

جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی

Concise Antibiogram Toolkit Background

21 st Expert Committee on Selection and Use of Essential Medicines Peer Review Report Antibiotics Review

2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

EUCAST recommended strains for internal quality control

Absolutely fragilis - A case discussion

Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST

Empiric Treatment of Sepsis. Professor of Clinical Microbiology Department of Microbiology Leicester University U. K.

Give the Right Antibiotics in Trauma Mitchell J Daley, PharmD, BCPS

PVL Staph aureusjust a skin/soft tissue problem? Layla Mohammadi Lead Pharmacist, Antimicrobials Lewisham Healthcare NHS Trust

2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine

GENERAL NOTES: 2016 site of infection type of organism location of the patient

Chapter Anaerobic infections (individual fields): intraperitoneal infections (acute peritonitis, hepatobiliary infections, etc.

Antimicrobial Susceptibility Patterns

number Done by Corrected by Doctor Dr.Malik

Introduction to Chemotherapeutic Agents. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018

Community-Associated C. difficile Infection: Think Outside the Hospital. Maria Bye, MPH Epidemiologist May 1, 2018

3/20/2011. Code 215 of Hammurabi: If a physician performed a major operation on

Dr. Shaiful Azam Sazzad. MD Student (Thesis Part) Critical Care Medicine Dhaka Medical College

Antimicrobial Prophylaxis in the Surgical Patient. M. J. Osgood

a. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.

Prescribing Guidelines for Outpatient Antimicrobials in Otherwise Healthy Children

Antimicrobial Therapy

Responsible use of antibiotics

Aminoglycosides. Spectrum includes many aerobic Gram-negative and some Gram-positive bacteria.

Similar to Penicillins: -Chemically. -Mechanism of action. -Toxicity.

Enterobacter aerogenes

Secondary bacterial infections complicating skin lesions

Table 1. Commonly encountered or important organisms and their usual antimicrobial susceptibilities.

USA Product Label CLINTABS TABLETS. Virbac. brand of clindamycin hydrochloride tablets. ANADA # , Approved by FDA DESCRIPTION

number Done by Corrected by Doctor

Skin & Soft Tissue Infections (SSTIs)

11/10/2016. Skin and Soft Tissue Infections. Disclosures. Educational Need/Practice Gap. Objectives. Case #1

Principles of Infectious Disease. Dr. Ezra Levy CSUHS PA Program

Grey Nuns Community Hospital (GNCH) Antimicrobial Stewardship Report

MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC

Surgical Site Infections (SSIs)

Principles of Antibiotics Use & Spectrum of Some

Antimicrobial susceptibility

January 2014 Vol. 34 No. 1

IDSA GUIDELINES EXECUTIVE SUMMARY

Int.J.Curr.Microbiol.App.Sci (2017) 6(3):

DRAFT DRAFT. Paediatric Antibiotic Prescribing Guideline. May

2017 SURVEILLANCE OF SURGICAL SITES INFECTIONS FOLLOWING TOTAL HIP AND KNEE ARTHROPLASTY

CONTAGIOUS COMMENTS Department of Epidemiology

Transcription:

Anaerobic infections: antibiotic therapy and development of resistance Inge C Gyssens 1 0ctober 2014

Objectives To review the clinical aspects of some anaerobic infections To understand the epidemiology of resistance of anaerobic bacteria To discuss two clinical cases of infection on 2 different anatomical sites To choose appropriate therapy from the arsenal of old and new antibiotics

Pathogenesis: the bacteria and the host

Pathogenesis of anaerobic infections Bacterial contamination x Virulence = Risk of Host defense Infection

Characteristics of anaerobic bacteria Virulence: endotoxin Synergy in «mixed infection» E. coli and B. fragilis Streptococci and B. fragilis Enterococci and B. fragilis Anaerobic gram positive cocci Pus: Abscess formation

Bacteroides fragilis cell envelope Polysaccharide capsule is involved in abscess formation

Fusobacterium sp virulence factors Lipopolysaccharide endotoxin capable of causing an intense systemic sepsis. Haemolysin, contributing to abscess formation Haemagglutinin, of which the relevance to pathogenesis of human infection is uncertain Fimbrae for adhesion to host cells Capability to cause platelet aggregation, which may help to promote a favourable anaerobic environment for survival of the organism in abscesses Synergy with other bacteria (Group C streptococci) /viruses (EBV)

Host factors Age Site of infection Impaired immunity Adapted immunity Polymorphonuclear leukocytes T lymphocytes Innate immunity (research)

Innate immunity pathways Trinchieri G, Sher A. Nat Rev Immunol. 2007; 7(3): 179-90

Cytokine profile induced by B. fragilis Concentration (pg/ml) Stappers et al. Cytokine 2012 *** 80000 RPMI 60000 B. fragilis 40000 S. aureus 20000 *** 1000 800 600 400 *** *** *** 200 0 IL-1 IL-6 IL-8 IL-17 TNF- n: 74 74 74 74 72 (RPMI) 63 63 63 74 61 (Bf) 66 66 66 74 64 (Sa) ***: p<0.0001

SNPs in NOD2 reduce B. fragilis induced cytokine production M Stappers et al. Cytokine 2012

Clinical aspects of anaerobic infections

Clinical disease varies according to site A. Skin and skin structure infections Necrotising fasciitis Gas gangrene Diabetic foot B. Perforation of the gastrointestinal tract Head & Neck infections Parodontal infections Peritonsillar or retropharyngeal abscess following tonsillitis Lemierre Syndrome Mediastinitis Actinomycosis Abdominal sepsis Pseudomembranous colitis (Uro)- anogenital infections.. With or without abscess formation

Anaerobic infections A. Skin and skin structure infections Necrotising fasciitis Gas gangrene Diabetic foot

Anatomy of Skin and Skin structure infections From: P. Kujath. Haut- und Weichgewebsinktionen, UNI-MED, 2004, Bremen

Clinical aspects of deep abscesses Antibiotics have impaired activity in well formed abscesses Drainage is required in most cases Factors influencing the activity of antibiotics: low oxygen content (anaerobic milieu) low ph in the abscess

csssi Most frequent pathogens Staphylococcus aureus Streptococci but

Pathogens encountered in csssi studies Tan et al, AAC 1993 Graham et al, CID 2003

Necrotising fasciitis

Treatment of csssi Principles Optimal antibiotic regimen but Sufficient and rapid surgical debridement

Diabetic foot ulcer infection The major risk factor for severe infection is peripheral arterial disease The Eurodiale study Prompers et al.

433 patients 427 positive cultures; 83% polymicrobial, 48% only aerobes 43,7% both aerobes and anaerobes, 1,3% only anaerobes. Cultures yielded a total of 1145 aerobic and 462 anaerobic strains, with an average of 2.7 organisms (range 1 to 8) for aerobes and 2.3 organisms per culture (range 1 to 9) for anaerobes

Bacteroides spp resistance percentages, range United States 2006-2009 Snydman Anaerobe 2011 Spain 2006-2010 Trevino Anaerobe 2012 Taiwan Liu AAC 2008 blood N Zealand 1999-2003 Roberts JAC 2006 Belgium 2011-2012 Wybo JAC 2014 N=1957 N =1343 N=113 N=100 N= 180 metronidazole 1+1 isolate 0 0 0 0 clindamycin 19 60 33-49 37-43 6 42 coamoxiclav NA 5-21 23-33 6-14 13 cefoxitin 3-23 6-25 NA 0-6 44 moxifloxacin 29 88 17-28 7-24 NA 38 tigecycline 0 14 6-10.5 NA NA NA piperacillin/tazobactam NA 0-3 0-4 0-2 15 imipenem/meropenem/ ertapenem 0 5 0 0.6 0-4/0-5 0-2/2-4 8 chloramphenicol 0 0 3-4 NA 3

Diabetic foot infection in hospital: therapy No previous antibiotics, no severe peripheral arterial disease: Amoxicillin clavulanic acid iv Switch to clindamycin orally or flucloxacillin if culture shows gram positive pathogens Previous antibiotics, severe peripheral arterial disease Piperacillin tazobactam Carbapenem.. Switch to fluoroquinolone and clindamycin orally guided by culture data

Clinical entities vary according to site B. Perforation of the digestive tract Head & Neck infections Parodontal infections Retropharyngeal peritonsillar abscess following tonsillitis Lemierre Syndrome Mediastinitis Actinomycosis Abdominal sepsis Pseudomembranous colitis (Uro)- anogenital infections.. with or without abscess formation

ischiorectal abscess Skin flora or bowel flora? King M, Ed. Primary surgery vol 1 Non-trauma. Oxford University Press, Oxford, 2003

! Essential treatment component: Surgical debridement From: P. Kujath. Haut- und Weichgewebsinktionen, UNI-MED, 2004, Bremen

Diagnostics Imaging Sample collection Laboratory Identification and susceptibility

Routine anaerobic blood cultures, yes or no? Lassman et al. Clin Infect Dis 2007 Editorial by Hecht Clin Infect Dis 2007 It seems less predictable than it used to be when anaerobic pathogens play a role

Antibacterials active against anaerobes Beta-lactams Interfere with cell wall synthesis: penicillins /+ betalactamase inhibitors, amoxicillin clavulanic acid, piperacillin tazobactam, cefalosporins Protein synthesis inhibitors (antiribosomal antibiotics): clindamycin, tigecycline Inhibitors of DNA synthesis gyrase/topoisomerase II: newer quinolones metronidazole

Interpreting surveillance susceptibility data Wybo et al 2014

Case 1 A boy with a painful swelling of the neck 17-year old boy has returned home from a summer camp 2 days ago. He has fever 38.9 C and severe pain on the left side of his neck. He was prescribed oral amoxicillin clavulanic acid by his GP on the first day of his return but today he has vomited and is sent to the emergency department. On examination he has a very painful bulging swelling on the left side of his neck.

Case 1 A boy with a painful swelling of the neck Q1 What is your differential diagnosis? Q2 Which laboratory tests should be performed? Q3 Imaging?

A life-threatening sore throat masquerading as swine flu Kahr et al, Lancet 2010 February 375: 524 Left : Absence of contrast within proximal left internal jugular vein indicates thrombosis. Right: Complete opacification of the middle ear cleft with further soft tissue within the external auditory canal.

Case 1 A boy with a painful swelling of the neck At drainage, the surgeon only requested aerobic cultures of the pus, which yielded no growth. However, from the enrichment medium Fusobacterium necrophorum was grown and reported after 3 days

Treating infections caused by Fusobacterium necrophorum and spp., resistance percentages, range UK 1990-2000 Brazier Anaerobe 2006 Taiwan Liu AAC 2008 blood Netherlands 2011-2013 Veloo Anaerobe 2014 Belgium 2011-2012 Wybo Anaerobe 2014 N= 100 N = 27 N = 39 N = 21 penicillin/amoxicillin 2 11 /15 19 metronidazole 0 0 0 0 clindamycin 0 4 0 19 coamoxiclav 0 7 5 0 cefoxitin 0 NA 0 0 erythromycin 15 NA NA NA tetracycline 1 NA NA NA moxifloxacin NA 0 NA 29 piperacillin/tazobactam NA 0 NA 0 imipenem/meropenem 0 4/8 NA 0 chloramphenicol 0 4 NA 0

Case 2 Intraabdominal abscess following intestinal perforation Case A 58 year old man, mr F., is diagnosed with lung carcinoma T4 N2 M0 (stage IIIb). He is treated with three-weekly courses of cisplatin/ etoposide and gemcitabine. Side effects consist of severe constipation. Two months later, after three courses of chemotherapy, he is readmitted with a history of worsening constipation and abdominal pain. On physical examination paralytic ileus is suspected. The next day his temperature is 38.5 C and the nurses draw blood cultures. One day later, symptoms become more severe and a plain X-Ray of the abdomen is compatible with intestinal perforation. This is confirmed by laparotomy. There is faecal spill in the abdominal cavity. Secundary peritonitis is diagnosed.

Case 2 Intraabdominal abscess following intestinal perforation Q1 What would be the empirical antimicrobial regimen in your hospital? Sources: - - antibiotic guide of your hospital - national antibiotic guidelines

Antibiotic therapy for secondary peritonitis, NL ceftriaxone iv 2000mg 1dd +metronidazole iv 500mg 3dd 5 to 14 days + aminoglycoside iv 1dd cefotaxime iv 1000mg 4dd + metronidazole iv 500mg 3dd 5 to 14 days + aminoglycoside iv 1dd cefuroxime iv 1500mg 3dd + metronidazole iv 500mg 3dd 5 to 14 days + aminoglycoside iv 1dd amoxicillin iv 1000mg 4dd + metronidazole iv 500mg 3dd 5 to 14 days + aminoglycoside iv 1dd amoxicillin + clavulanic acid iv 1000/200mg 4dd 5 to 14 days + aminoglycoside iv 1dd www.swab.nl

Case 2 Intraabdominal abscess following intestinal perforation Case continued The surgeon has prescribed amoxicillin clavulanic acid, 1000/200 mg iv four times daily. On the next day, the anaerobic bottles of 2 pairs of blood cultures grow gram negative bacillae, identified as Bacteroides stercoris.

Case 2 Intraabdominal abscess following intestinal perforation Q2 Should susceptibility testing be performed? Q3 Which antimicrobials should be tested? Q4 Would you change the antibiotic regimen? (antibiotic, schedule, duration)

Case 2 Intraabdominal abscess following intestinal perforation Case continued Six days later, the temperature is 39 C. Mr. F. is still treated with amoxicillin clavulanic acid. He complains of right flank pain. The abdomen is tender on palpation. Susceptibility testing reveals intermediary resistance (I) to amoxicillin clavulanic acid. A CT scan of the abdomen shows several paracolic fluid collections, suggestive of abscess formation. The patient has clinical sepsis. A relaparotomy is performed. Pus from two large abscesses is drained and the surgeon calls you for advice.

Case 2 Intraabdominal abscess following intestinal perforation Q5 What is your advice on laboratory diagnostics and antimicrobial therapy now?

MIC 50, MIC 90 and Resistance of anaerobes in the Netherlands

Case 2 Intraabdominal abscess following intestinal perforation After 2 days, two different anaerobe gram negative rods are cultured from the drained pus. Q6 Should susceptibility testing be performed? Q7 What is your advice on antimicrobial therapy?

Bacteroides spp resistance percentages, range United States 2006-2009 Snydman Anaerobe 2011 Spain 2006-2010 Trevino Anaerobe 2012 Taiwan Liu AAC 2008 blood N Zealand 1999-2003 Roberts JAC 2006 Belgium 2011-2012 Wybo JAC 2014 N=1957 N =1343 N=113 N=100 N= 180 metronidazole 1+1 isolate 0 0 0 0 clindamycin 19 60 33-49 37-43 6 42 coamoxiclav NA 5-21 23-33 6-14 13 cefoxitin 3-23 6-25 NA 0-6 44 moxifloxacin 29 88 17-28 7-24 NA 38 tigecycline 0 14 6-10.5 NA NA NA piperacillin/tazobactam NA 0-3 0-4 0-2 15 imipenem/meropenem/ ertapenem 0 5 0 0.6 0-4/0-5 0-2/2-4 8 chloramphenicol 0 0 3-4 NA 3

Lofmark et al

Snydman et al Anaerobe 2011

Conclusion Which antibiotic to select for anaerobic infections? Empirical therapy Beta lactamase inhibitors: amoxicillin clavulanic acid, piperacillin tazobactam Cefuroxime or ceftriaxone + metronidazole Carbapenems: imipenem, meropenem, ertapenem (Tigecycline) Definitive therapy : «narrow spectrum» Penicillin Metronidazole Clindamycin Newer quinolones: moxifloxacin.